Congratulations Mithra, page-14

Your concerns are genuine and very well expressed.
In pharma there is no certainty most of the time ,
unless it is a drug that is to be fast tracked on priority basis by the authorities.
I am certain no one will be happy with 5% equity being handed over NOW ... even when drug is not approved.Not sure if that is the case as it stands.
Potential is big...and if this one and Nuva comes in good then ...MYX is launched straight into big league orbit in pharma internationally.
It will provide lot of further opportunities then for accelerated growth.
Pharma has been v v dicey and v v risky in terms of approvals and R N D expns over the last 20-30 years.Hence so many mergers and down sizing.